产品信息
| 产品号 | 商品名 | 活性成分 | 剂型/给药途径 | 规格/剂量 | 参比药物(RLD) | 生物等效参考标准(RS) | 治疗等效代码 | 该申请号批准日期 | 该产品号批准日期 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|
| 001 | DAPZURA RT | DAPTOMYCIN | POWDER;INTRAVENOUS | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Yes | No | None | 2022/01/25 | 2022/01/25 | Discontinued |
| 002 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | DAPTOMYCIN | SOLUTION;INTRAVENOUS | 350MG/50ML (7MG/ML) | Yes | Yes | None | 2023/02/27 | Prescription | |
| 003 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | DAPTOMYCIN | SOLUTION;INTRAVENOUS | 500MG/50ML (10MG/ML) | Yes | Yes | None | 2023/02/27 | Prescription | |
| 004 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | DAPTOMYCIN | SOLUTION;INTRAVENOUS | 700MG/100ML (7MG/ML) | Yes | Yes | None | 2023/02/27 | Prescription | |
| 005 | DAPTOMYCIN IN 0.9% SODIUM CHLORIDE | DAPTOMYCIN | SOLUTION;INTRAVENOUS | 1GM/100ML (10MG/ML) | Yes | Yes | None | 2023/02/27 | Prescription |
